Anti‐ epithelial cell adhesion molecule RNA aptamer‐conjugated liposomal doxorubicin as an efficient targeted therapy in mice bearing colon carcinoma tumor model
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti‐
epithelial cell adhesion molecule
RNA
aptamer‐conjugated liposomal doxorubicin as an efficient targeted therapy in mice bearing colon carcinoma tumor model
Authors
Keywords
-
Journal
BIOTECHNOLOGY PROGRESS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-12-25
DOI
10.1002/btpr.3116
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preparation and characterization of stable nanoliposomal formulations of curcumin with high loading efficacy: In vitro and in vivo anti-tumor study
- (2020) Maryam Karimi et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Anti-Epcam Aptamer (Syl3c)-Functionalized Liposome for Targeted Delivery Of Doxorubicin: In Vitro And In Vivo Antitumor Studies in Mice Bearing C26 Colon Carcinoma
- (2020) Mohammad Mashreghi et al. Nanoscale Research Letters
- Combination therapy with liposomal doxorubicin and liposomal vaccine containing E75, an HER-2/neu-derived peptide, reduces myeloid-derived suppressor cells and improved tumor therapy
- (2020) Parvin Zamani et al. LIFE SCIENCES
- MPL nano-liposomal vaccine containing P5 HER2/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer
- (2019) Parvin Zamani et al. JOURNAL OF CONTROLLED RELEASE
- EpCAM Aptamer-Functionalized Cationic Liposome-Based Nanoparticles Loaded with miR-139-5p for Targeted Therapy in Colorectal Cancer
- (2019) Yuyu Zhao et al. MOLECULAR PHARMACEUTICS
- Tumor targeting via EPR: Strategies to enhance patient responses
- (2018) Susanne K. Golombek et al. ADVANCED DRUG DELIVERY REVIEWS
- A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: From liposomal preparation to therapy
- (2018) Hamidreza Farzaneh et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer
- (2017) Yang Li et al. International Journal of Nanomedicine
- PNC27 anticancer peptide as targeting ligand significantly improved antitumor efficacy of Doxil in HDM2-expressing cells
- (2017) Shahrzad Amiri Darban et al. Nanomedicine
- Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model
- (2016) Seyedeh Alia Moosavian et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Liposomal drug delivery systems for targeted cancer therapy: is active targeting the best choice?
- (2016) Shaghayegh Fathi et al. Future Medicinal Chemistry
- Multivalent Aptamers: Versatile Tools for Diagnostic and Therapeutic Applications
- (2016) Mariya Vorobyeva et al. MOLECULES
- Aptamers: A promising chemical antibody for cancer therapy
- (2016) Gang Zhou et al. Oncotarget
- Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin
- (2015) Leila Arabi et al. JOURNAL OF CONTROLLED RELEASE
- Principles of nanoparticle design for overcoming biological barriers to drug delivery
- (2015) Elvin Blanco et al. NATURE BIOTECHNOLOGY
- Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors
- (2015) Dongxi Xiang et al. Theranostics
- Nucleic Acid Aptamers: New Methods for Selection, Stabilization, and Application in Biomedical Science
- (2014) Hoon Young Kong et al. Biomolecules & Therapeutics
- EpCAM-targeted liposomal si-RNA delivery for treatment of epithelial cancer
- (2014) Dhiraj Bhavsar et al. DRUG DELIVERY
- Improving the distribution of Doxil® in the tumor matrix by depletion of tumor hyaluronan
- (2014) Aditya G. Kohli et al. JOURNAL OF CONTROLLED RELEASE
- RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo
- (2014) Si Eun Baek et al. JOURNAL OF CONTROLLED RELEASE
- Improvement of pharmacokinetic and antitumor activity of PEGylated liposomal doxorubicin by targeting with N-methylated cyclic RGD peptide in mice bearing C-26 colon carcinomas
- (2013) Mohamadreza Amin et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule
- (2011) Sarah Shigdar et al. CANCER SCIENCE
- Chimeric aptamers in cancer cell-targeted drug delivery
- (2011) Jagat R. Kanwar et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- The Ligand Nanoparticle Conjugation Approach for Targeted Cancer Therapy
- (2011) Nour Karra et al. CURRENT DRUG METABOLISM
- Specific Targeting of Ep-CAM in Various Carcinomas by Novel Monoclonal Antibodies
- (2011) Devilakshmi Sithambaram et al. HYBRIDOMA
- Targeted drug delivery to tumors: Myths, reality and possibility
- (2011) You Han Bae et al. JOURNAL OF CONTROLLED RELEASE
- EpCAM in carcinogenesis: the good, the bad or the ugly
- (2010) B. T. F. van der Gun et al. CARCINOGENESIS
- To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
- (2010) Fabienne Danhier et al. JOURNAL OF CONTROLLED RELEASE
- A liposome-based nanostructure for aptamer directed delivery
- (2009) Huaizhi Kang et al. CHEMICAL COMMUNICATIONS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now